2,172
|
18189 |
Obesity
|
|
increases_quantity of
|
Angiotensin III
|
in blood
|
|
15191907
|
Diabetes mellitus, type II
Obesity
Insulin resistance
|
11,921
|
117262 |
ENPEP
|
|
increases_quantity of
|
Angiotensin III
|
in hypothalamus
|
117263 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
in hypothalamus
|
117266 |
Angiotensin III
|
|
increases_activity of
|
vasopressin secretion
|
in brain
|
117267 |
Angiotensin III
|
|
increases_activity of
|
brain renin-angiotensin system
|
in brain
|
119255 |
Angiotensin II
|
|
increases_quantity of
|
Angiotensin III
|
in hypothalamus
|
119257 |
Angiotensin III
|
|
increases_quantity of
|
Angiotensin IV
|
in hypothalamus
|
|
8876246
|
Cardiovascular disease
|
11,933
|
117310 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR1
|
in HEK293 cells
|
117313 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR2
|
in HEK293 cells
|
|
21542804
|
Cardiovascular disease
|
12,029
|
118026 |
Angiotensin III
|
|
increases_activity of
|
MAS1
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
12,035
|
118077 |
ENPEP
|
|
increases_quantity of
|
Angiotensin III
|
|
118081 |
ACE
|
|
increases_quantity of
|
Angiotensin III
|
|
118084 |
Angiotensin III
|
|
increases_activity of
|
AGTR1
|
|
118085 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
|
118086 |
Angiotensin III
|
|
increases_activity of
|
positive regulation of blood pressure
|
|
118087 |
Angiotensin III
|
|
increases_activity of
|
vasopressin secretion
|
|
118088 |
Angiotensin III
|
|
increases_activity of
|
aldosterone secretion
|
|
118089 |
Angiotensin III
|
|
increases_activity of
|
inflammatory response
|
|
118090 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
12,036
|
118083 |
ACE
|
|
increases_quantity of
|
Angiotensin III
|
|
|
|
Cardiovascular disease
|
12,056
|
118320 |
ENPEP
|
|
increases_quantity of
|
Angiotensin III
|
|
118321 |
Angiotensin III
|
|
increases_activity of
|
positive regulation of blood pressure
|
|
118322 |
Angiotensin III
|
|
increases_activity of
|
vasopressin secretion
|
|
118323 |
Angiotensin III
|
|
increases_activity of
|
positive regulation of thirst
|
|
118324 |
Angiotensin III
|
|
increases_activity of
|
aldosterone secretion
|
|
118325 |
Angiotensin III
|
|
increases_activity of
|
inflammatory response
|
|
118326 |
Angiotensin III
|
|
increases_activity of
|
extracellular matrix organization
|
|
118327 |
Angiotensin III
|
|
increases_activity of
|
AGTR1
|
|
118328 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
|
118329 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
|
|
19065996
|
Diabetes mellitus, type II
Insulin resistance
|
12,194
|
119790 |
Angiotensin II
|
|
increases_quantity of
|
Angiotensin III
|
|
119791 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR1
|
|
119792 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR2
|
|
119793 |
Angiotensin III
|
|
affects_activity of
|
regulation of blood pressure
|
|
119794 |
Angiotensin III
|
|
increases_quantity of
|
Angiotensin IV
|
via aminopeptidase
|
|
32127770
|
Neurodegenerative disorder
|
13,915
|
131420 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
|
|
31030607
|
Renal
|
14,067
|
132931 |
Angiotensin III
|
|
increases_activity of
|
COVID-19, severe
|
|
132951 |
chymase pathway
|
|
increases_quantity of
|
Angiotensin III
|
|
132957 |
ENPEP
|
|
increases_quantity of
|
Angiotensin III
|
|
132958 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
|
132960 |
Angiotensin III
|
|
increases_activity of
|
vasopressin secretion
|
in brain
|
132961 |
Angiotensin III
|
|
increases_activity of
|
aldosterone secretion
|
|
132962 |
Angiotensin III
|
|
increases_activity of
|
AGTR1
|
|
132963 |
Angiotensin III
|
|
increases_activity of
|
vasoconstriction
|
via AGTR1
|
132964 |
Angiotensin III
|
|
increases_activity of
|
inflammatory response
|
via AGTR1
|
|
33169633
|
COVID-19
|
14,145
|
133624 |
Angiotensin III
|
|
increases_quantity of
|
CCL2
|
in HK-2 cells; via AGTR1
|
133709 |
Losartan
|
|
decreases_activity of
|
Angiotensin III
|
in HK-2 cells; via AGTR1
|
133710 |
Angiotensin III
|
|
increases_activity of
|
p38MAPK cascade
|
in HK-2 cells
|
133711 |
Angiotensin III
|
|
increases_activity of
|
JNK cascade
|
in HK-2 cells
|
|
26767865
|
Nephropathy, diabetic
|
14,159
|
133796 |
Angiotensin II
|
|
increases_quantity of
|
Angiotensin III
|
in neurons
|
|
23213621
|
Parkinson disease
|
14,176
|
136134 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
in kidney
|
|
19065132
|
Nephropathy, diabetic
|
14,205
|
134089 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
|
|
1978675
|
Cardiovascular disease
|
14,207
|
134122 |
Angiotensin II
|
|
increases_quantity of
|
Angiotensin III
|
in brain; via ENPEP (APA)
|
134123 |
Angiotensin III
|
|
increases_quantity of
|
Angiotensin IV
|
in brain; via ANPEP (APN)
|
134125 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR1
|
in brain
|
134127 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR2
|
in brain
|
134129 |
Angiotensin III
|
|
increases_activity of
|
positive regulation of blood pressure
|
via AGTR1
|
134131 |
Angiotensin III
|
|
increases_activity of
|
angiotensin-mediated drinking behavior
|
via AGTR1
|
134133 |
Angiotensin III
|
|
increases_activity of
|
pituitary hormone secretion
|
via AGTR1
|
134135 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
in brain
|
134137 |
Angiotensin III
|
|
increases_activity of
|
vasopressin secretion
|
|
|
11295571
|
Cardiovascular disease
|
14,208
|
134097 |
Angiotensin III
|
|
increases_expression of
|
FOS
|
in renal interstitial fibroblasts
|
134138 |
Angiotensin III
|
|
increases_expression of
|
TGFB1
|
in mesangial cells, in renal interstitial fibroblasts
|
134139 |
Angiotensin III
|
|
increases_quantity of
|
FN1
|
in mesangial cells, in renal interstitial fibroblasts
|
134140 |
Angiotensin III
|
|
increases_expression of
|
AGT
|
in mesangial cells, in renal interstitial fibroblasts
|
134141 |
Angiotensin III
|
|
increases_activity of
|
extracellular matrix accumulation
|
in mesangial cells, in renal interstitial fibroblasts
|
|
9839282
|
Chronic kidney disease
|
14,209
|
134099 |
Angiotensin III
|
|
increases_expression of
|
CCL2
|
|
134142 |
Angiotensin III
|
|
increases_activity of
|
NF-kappaB complex
|
|
134143 |
Angiotensin III
|
|
increases_activity of
|
JUN
|
|
|
10844599
|
Chronic kidney disease
|
14,230
|
134340 |
Angiotensin III
|
|
increases_activity of
|
ERK1 and ERK2 cascade
|
in astrocytes
|
134342 |
Angiotensin III
|
|
increases_activity of
|
JNK cascade
|
in astrocytes
|
|
23476748
|
Cardiovascular disease
|
14,231
|
134367 |
ENPEP
|
|
increases_quantity of
|
Angiotensin III
|
|
134368 |
ANPEP
|
|
decreases_quantity of
|
Angiotensin III
|
|
134370 |
Angiotensin III
|
|
increases_activity of
|
AGTR1
|
|
134371 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
|
134375 |
Angiotensin III
|
|
increases_quantity of
|
Angiotensin (3-4)
|
in blood plasma
|
|
30978131
|
Cardiovascular disease
|
14,232
|
134423 |
Angiotensin III
|
|
increases_activity of
|
NF-kappaB complex
|
in mesangial cells; via AGTR2
|
|
11961003
|
Nephropathy, diabetic
|
14,324
|
135205 |
Angiotensin III
|
|
increases_activity of
|
increased urine sodium level
|
by stimulating AGTR2
|
|
23407646
|
Renal
|
14,328
|
135204 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
in kidney; after blockade of AGTR1
|
|
16380540
|
Renal
|
14,332
|
135220 |
Angiotensin III
|
|
decreases_activity of
|
renal sodium ion absorption
|
in kidney
|
135222 |
Angiotensin III
|
|
increases_activity of
|
increased urine sodium level
|
|
|
31030607
|
Renal
|
14,340
|
135258 |
Angiotensin II
|
|
increases_quantity of
|
Angiotensin III
|
in kidney; via enzymatic activity of aminopeptidaseA
|
135262 |
ENPEP
|
|
increases_quantity of
|
Angiotensin III
|
in kidney
|
135266 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
in kidney
|
|
18158338
|
Renal
|
14,343
|
135275 |
Angiotensin III
|
|
increases_activity of
|
AGTR2
|
in the proximal tubule
|
|
22689743
|
Renal
|